India’s Elder Subject Of Probe By Authorities
This article was originally published in PharmAsia News
Indian authorities have begun an investigation into the accounts of Elder Pharmaceuticals, suspecting it of keeping false accounts to defraud investors. Government sources say Elder already had confirmed it filed false tax accounts to settle another case, but the more recent probe is said to be aimed at a siphoning of investor funds. A company spokesman said the incident involves only a single reference in a financial statement that was corrected after the government pointed it out. (Click here for more
You may also be interested in...
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.
Cambridge Nutraceuticals - which develops dietary supplements that have “proven clinical benefits” - has snapped up UK-based Prime Fifty to enhance its offering with products specifically designed for the over 50s.
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.